LinkOPH

WAILEA, Hawaii – Vision gains achieved at the conclusion of the RIDE/RISE studies were maintained in patients with diabetic macular edema who were enrolled in a 2-year open-label extension study, Michael S. Ip, MD, told colleagues at Retina 2015. Improvements in retinopathy level were also sustained.After 3 years in RIDE/RISE, 500 participants entered an open-label extension in which Lucentis 0.5 mg (ranibizumab, Genentech) was given as needed in all three treatment arms according to re-treatment criteria. Mean follow-up time was 14.1 months, less than the anticipated 24 months due to (Read more...)

WAILEA, Hawaii – Measuring visual field by optical coherence tomography can be useful in tracking glaucoma progression, according to a speaker here.“We now know that we can detect glaucoma earlier than we ever could before. What we are detecting structurally by OCT is really glaucoma,” Joel S. Schuman, MD, FACS, said at the Hawaiian Eye 2015 meeting.

Read more →

WAILEA, Hawaii – Retina specialists can help shape patient behavior that can modify the progression of diabetic retinopathy, a speaker said at Retina 2015.“As retina specialists, we have a responsibility to change behavior, not only because [diabetic retinopathy] is the number one cause of blindness in working age adults, but more importantly because diabetic patients fear blindness,” Allen S. Ho, MD, said.Consequently, retina specialists have more opportunity to influence their patients’ behavior because they see diabetic patients more often than they see their primary care doctor.Controlling hemoglobin A1c levels and (Read more...)

WAILEA, Hawaii – Cataract surgeons should carefully weigh the pluses and minuses of traditional and femtosecond laser-assisted cataract surgery techniques, and adjust patient expectations accordingly, a speaker said here.Addressing colleagues at Hawaiian Eye 2015, Kendall E. Donaldson, MD, MS, compared traditional cataract surgery to methods performed with four femtosecond lasers: Catalys (Abbott Medical Optics), LenSx (Alcon), Victus (Bausch + Lomb) and LensAR.

Read more →

WAILEA, Hawaii – The most significant lesson learned from the HARBOR study is that individualization of patient care achieves best results when it comes to the treatment of age-related macular degeneration, a presenter said here.“Simply treating all patients the same is not good medicine,” Pravin U. Dugel, MD,said at Retina 2015.

Read more →